237 related articles for article (PubMed ID: 19635932)
1. The urokinase receptor supports tumorigenesis of human malignant pleural mesothelioma cells.
Tucker TA; Dean C; Komissarov AA; Koenig K; Mazar AP; Pendurthi U; Allen T; Idell S
Am J Respir Cell Mol Biol; 2010 Jun; 42(6):685-96. PubMed ID: 19635932
[TBL] [Abstract][Full Text] [Related]
2. A urokinase receptor mRNA binding protein-mRNA interaction regulates receptor expression and function in human pleural mesothelioma cells.
Shetty S; Idell S
Arch Biochem Biophys; 1998 Aug; 356(2):265-79. PubMed ID: 9705217
[TBL] [Abstract][Full Text] [Related]
3. Urokinase-type plasminogen activator receptor promotes proliferation and invasion with reduced cisplatin sensitivity in malignant mesothelioma.
Wang S; Jiang L; Han Y; Chew SH; Ohara Y; Akatsuka S; Weng L; Kawaguchi K; Fukui T; Sekido Y; Yokoi K; Toyokuni S
Oncotarget; 2016 Oct; 7(43):69565-69578. PubMed ID: 27602956
[TBL] [Abstract][Full Text] [Related]
4. BioKnife, a uPA activity-dependent oncolytic Sendai virus, eliminates pleural spread of malignant mesothelioma via simultaneous stimulation of uPA expression.
Morodomi Y; Yano T; Kinoh H; Harada Y; Saito S; Kyuragi R; Yoshida K; Onimaru M; Shoji F; Yoshida T; Ito K; Shikada Y; Maruyama R; Hasegawa M; Maehara Y; Yonemitsu Y
Mol Ther; 2012 Apr; 20(4):769-77. PubMed ID: 22314292
[TBL] [Abstract][Full Text] [Related]
5. Posttranscriptional regulation of urokinase receptor gene expression in human lung carcinoma and mesothelioma cells in vitro.
Shetty S; Idell S
Mol Cell Biochem; 1999 Sep; 199(1-2):189-200. PubMed ID: 10544967
[TBL] [Abstract][Full Text] [Related]
6. Functional Analysis of the Adrenomedullin Pathway in Malignant Pleural Mesothelioma.
Greillier L; Tounsi A; Berenguer-Daizé C; Dussault N; Delfino C; Benyahia Z; Cayol M; Mabrouk K; Garcia S; Martin PM; Barlesi F; Ouafik L
J Thorac Oncol; 2016 Jan; 11(1):94-107. PubMed ID: 26762744
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic down-regulation of integrin α7 increases migratory potential and confers poor prognosis in malignant pleural mesothelioma.
Laszlo V; Hoda MA; Garay T; Pirker C; Ghanim B; Klikovits T; Dong YW; Rozsas A; Kenessey I; Szirtes I; Grusch M; Jakopovic M; Samarzija M; Brcic L; Kern I; Rozman A; Popper H; Zöchbauer-Müller S; Heller G; Altenberger C; Ziegler B; Klepetko W; Berger W; Dome B; Hegedus B
J Pathol; 2015 Oct; 237(2):203-14. PubMed ID: 26011651
[TBL] [Abstract][Full Text] [Related]
8. Urokinase receptor in human malignant mesothelioma cells: role in tumor cell mitogenesis and proteolysis.
Shetty S; Kumar A; Johnson A; Pueblitz S; Idell S
Am J Physiol; 1995 Jun; 268(6 Pt 1):L972-82. PubMed ID: 7611439
[TBL] [Abstract][Full Text] [Related]
9. Dysregulated Expression of the MicroRNA miR-137 and Its Target YBX1 Contribute to the Invasive Characteristics of Malignant Pleural Mesothelioma.
Johnson TG; Schelch K; Cheng YY; Williams M; Sarun KH; Kirschner MB; Kao S; Linton A; Klebe S; McCaughan BC; Lin RCY; Pirker C; Berger W; Lasham A; van Zandwijk N; Reid G
J Thorac Oncol; 2018 Feb; 13(2):258-272. PubMed ID: 29113949
[TBL] [Abstract][Full Text] [Related]
10. Radiation-inducible silencing of uPA and uPAR in vitro and in vivo in meningioma.
Rao Gogineni V; Kumar Nalla A; Gupta R; Gorantla B; Gujrati M; Dinh DH; Rao JS
Int J Oncol; 2010 Apr; 36(4):809-16. PubMed ID: 20198323
[TBL] [Abstract][Full Text] [Related]
11. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
[TBL] [Abstract][Full Text] [Related]
12. Asbestos upregulates expression of the urokinase-type plasminogen activator receptor on mesothelial cells.
Perkins RC; Broaddus VC; Shetty S; Hamilton S; Idell S
Am J Respir Cell Mol Biol; 1999 Nov; 21(5):637-46. PubMed ID: 10536123
[TBL] [Abstract][Full Text] [Related]
13. Expression and activity of eIF6 trigger malignant pleural mesothelioma growth in vivo.
Miluzio A; Oliveto S; Pesce E; Mutti L; Murer B; Grosso S; Ricciardi S; Brina D; Biffo S
Oncotarget; 2015 Nov; 6(35):37471-85. PubMed ID: 26462016
[TBL] [Abstract][Full Text] [Related]
14. Mesothelin overexpression promotes mesothelioma cell invasion and MMP-9 secretion in an orthotopic mouse model and in epithelioid pleural mesothelioma patients.
Servais EL; Colovos C; Rodriguez L; Bograd AJ; Nitadori J; Sima C; Rusch VW; Sadelain M; Adusumilli PS
Clin Cancer Res; 2012 May; 18(9):2478-89. PubMed ID: 22371455
[TBL] [Abstract][Full Text] [Related]
15. uPA/uPAR downregulation inhibits radiation-induced migration, invasion and angiogenesis in IOMM-Lee meningioma cells and decreases tumor growth in vivo.
Kargiotis O; Chetty C; Gogineni V; Gondi CS; Pulukuri SM; Kyritsis AP; Gujrati M; Klopfenstein JD; Dinh DH; Rao JS
Int J Oncol; 2008 Nov; 33(5):937-47. PubMed ID: 18949356
[TBL] [Abstract][Full Text] [Related]
16. RNA interference-mediated targeting of urokinase plasminogen activator receptor and matrix metalloproteinase-9 gene expression in the IOMM-lee malignant meningioma cell line inhibits tumor growth, tumor cell invasion and angiogenesis.
Tummalapalli P; Gondi CS; Dinh DH; Gujrati M; Rao JS
Int J Oncol; 2007 Jul; 31(1):5-17. PubMed ID: 17549400
[TBL] [Abstract][Full Text] [Related]
17. Posttranscriptional regulation of urokinase receptor mRNA: identification of a novel urokinase receptor mRNA binding protein in human mesothelioma cells.
Shetty S; Kumar A; Idell S
Mol Cell Biol; 1997 Mar; 17(3):1075-83. PubMed ID: 9032234
[TBL] [Abstract][Full Text] [Related]
18. Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro.
You M; Varona-Santos J; Singh S; Robbins DJ; Savaraj N; Nguyen DM
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):508-16. PubMed ID: 24094913
[TBL] [Abstract][Full Text] [Related]
19. Tissue factor pathway inhibitor attenuates the progression of malignant pleural mesothelioma in nude mice.
Williams L; Tucker TA; Koenig K; Allen T; Rao LV; Pendurthi U; Idell S
Am J Respir Cell Mol Biol; 2012 Feb; 46(2):173-9. PubMed ID: 21852688
[TBL] [Abstract][Full Text] [Related]
20. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
